Market Research Logo

Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review

Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection system and novel mab xpress antibody production system. Its pipeline products include clazakizumab and eptinezumab. Alder’s clazakizumab is a novel monoclonal antibody used for the treatment of rheumatoid arthritis and psoriatic arthritis. The company’s eptinezumab is an investigational product candidate for migraine prevention treatment for patients with chronic and frequent episodic migraine. Alder is headquartered in Bothell, Washington, the US.

Alder Biopharmaceuticals Inc Key Recent Developments

Nov 07,2017: Alder BioPharmaceuticals Announces Third Quarter 2017 Financial and Operating Results
Aug 08,2017: Alder BioPharmaceuticals Announces Second Quarter 2017 Financial and Operating Results
Apr 27,2017: Alder BioPharmaceuticals Announces First Quarter 2017 Financial and Operating Results
Apr 04,2017: Alder BioPharmaceuticals Appoints Wendy L. Yarno to its Board of Directors
Feb 23,2017: Alder BioPharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial and Operating Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Alder Biopharmaceuticals Inc - Key Facts 5
Alder Biopharmaceuticals Inc - Key Employees 6
Alder Biopharmaceuticals Inc - Key Employee Biographies 7
Alder Biopharmaceuticals Inc - Major Products and Services 8
Alder Biopharmaceuticals Inc - History 9
Alder Biopharmaceuticals Inc - Company Statement 10
Alder Biopharmaceuticals Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Alder Biopharmaceuticals Inc - Business Description 14
Alder Biopharmaceuticals Inc - Corporate Strategy 15
Alder Biopharmaceuticals Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Alder Biopharmaceuticals Inc - Strengths 16
Alder Biopharmaceuticals Inc - Weaknesses 17
Alder Biopharmaceuticals Inc - Opportunities 18
Alder Biopharmaceuticals Inc - Threats 19
Alder Biopharmaceuticals Inc - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Alder Biopharmaceuticals Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Nov 07, 2017: Alder BioPharmaceuticals Announces Third Quarter 2017 Financial and Operating Results 30
Aug 08, 2017: Alder BioPharmaceuticals Announces Second Quarter 2017 Financial and Operating Results 31
Apr 27, 2017: Alder BioPharmaceuticals Announces First Quarter 2017 Financial and Operating Results 33
Apr 04, 2017: Alder BioPharmaceuticals Appoints Wendy L. Yarno to its Board of Directors 35
Apr 04, 2017: Alder BioPharmaceuticals Appoints Wendy L. Yarno to its Board of Directors 36
Feb 23, 2017: Alder BioPharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial and Operating Results 37
Section 6 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
Alder Biopharmaceuticals Inc, Key Facts 5
Alder Biopharmaceuticals Inc, Key Employees 6
Alder Biopharmaceuticals Inc, Key Employee Biographies 7
Alder Biopharmaceuticals Inc, Major Products and Services 8
Alder Biopharmaceuticals Inc, History 9
Alder Biopharmaceuticals Inc, Subsidiaries 13
Alder Biopharmaceuticals Inc, Key Competitors 20
Alder Biopharmaceuticals Inc, Ratios based on current share price 21
Alder Biopharmaceuticals Inc, Annual Ratios 22
Alder Biopharmaceuticals Inc, Annual Ratios (Cont...1) 23
Alder Biopharmaceuticals Inc, Interim Ratios 25
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Alder Biopharmaceuticals Inc, Recent Deals Summary 29
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42
List of Figures
Alder Biopharmaceuticals Inc, Performance Chart (2012 - 2016) 24
Alder Biopharmaceuticals Inc, Ratio Charts 26
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report